H L Greene

Skin Cancer and Inorganic Arsenic: Uncertainty‐Status of Risk

K. G. Brown, K G Brown, H R Guo, 1997, Risk analysis : an official publication of the Society for Risk Analysis.

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

H L Greene, R. Peters, L. Mitchell, 1991, The New England journal of medicine.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

A L Waldo, H L Greene, M. Domanski, 2002, The New England journal of medicine.

A comparison of biphasic and monophasic shocks for external defibrillation. Physio-Control Biphasic Investigators.

Richard C. Nova, H L Greene, G S Greer, 2000, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

Comparison of monophasic and biphasic defibrillating pulse waveforms for transthoracic cardioversion. Biphasic Waveform Defibrillation Investigators.

P. D. Chapman, M J Reiter, H L Greene, 1995, The American journal of cardiology.

Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).

H L Greene, D. Roden, D. Roden, 1989, The American journal of cardiology.

Visualization of Cardiac Valve Motion in Man During External Chest Compression Using Two‐dimensional Echocardiography: Implications Regarding the Mechanism of Blood Flow

H L Greene, L. Cobb, H. Greene, 1981, Circulation.

The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.

H L Greene, D. Roden, H. Greene, 1992, Journal of the American College of Cardiology.

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.

M Huther, H L Greene, S Gottlieb, 1995, Journal of the American College of Cardiology.